FOGHORN THERAPEUTICS INC. - COMMON STOCK

Foghorn Therapeutics Presents New Preclinical Data on Novel BRG1/BRM Inhibitor FHD-286 at the 2022 AACR Annual Meeting

13 4月 2022 10:30:00 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics to Present Preclinical Data For FHD-286 at the 2022 AACR Annual Meeting

01 4月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics to Participate at the 2022 Guggenheim Targeted Protein Degradation Day

11 3月 2022 15:01:00 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics Provides Full Year 2021 Corporate Update and 2022 Outlook

10 3月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics to Participate at the Cowen’s 42nd Annual Health Care Conference

28 2月 2022 15:05:01 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics Announces Chief Scientific Officer Succession

10 1月 2022 06:00:02 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics to Participate at the H.C. Wainwright BioConnect Conference

07 1月 2022 15:05:00 条件 Nasdaq GlobeNewswire

Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn’s Proprietary Gene Traffic Control® Platform

13 12月 2021 05:00:00 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics to Participate at the 2021 Jefferies London Healthcare Conference

11 11月 2021 15:05:01 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics Provides Third Quarter 2021 Corporate Update

09 11月 2021 06:00:02 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics Announces Presentation at Upcoming 4th Annual Targeted Protein Degradation Summit

19 10月 2021 15:05:00 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics to Participate in Two Upcoming Virtual Investor Conferences

01 9月 2021 15:05:00 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics Announces First Patient Dosed in First-in-Human Clinical Trial of FHD-609

23 8月 2021 06:00:00 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics Provides Second Quarter 2021 Corporate Update

10 8月 2021 06:00:02 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference

03 8月 2021 07:30:00 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics to Participate at the William Blair Biotech Focus Conference 2021

09 7月 2021 07:36:31 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics to Host Research & Development Day Webinar on June 15th

08 6月 2021 06:00:01 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics to Present in Two Upcoming Investor Conferences

26 5月 2021 07:00:03 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Program of FHD-286

17 5月 2021 06:00:01 条件 Nasdaq GlobeNewswire

Foghorn Therapeutics Provides Corporate Update

11 5月 2021 06:00:02 条件 Nasdaq GlobeNewswire